Journal
/
/
Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
JoVE Journal
Medicine
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Medicine
Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring
DOI:

08:45 min

November 13, 2012

, , , ,

Chapters

  • 00:05Title
  • 01:33Tumor Model
  • 03:21PET Acquisition
  • 05:50CLI Acquisition
  • 06:58Results: PET and CLI Correlation
  • 07:43Conclusion

Summary

Automatic Translation

Use of Cerenkov Luminescence Imaging (CLI) for monitoring preclinical cancer treatment is described here. This method takes advantage of Cerenkov Radiation (CR) and optical imaging (OI) to visualize radiolabeled probes and thus provides an alternative to PET in preclinical therapeutic monitoring and drug screening.

Related Videos

Read Article